Reckitt’s Nuromol gains GSL status in the UK

19 August 2021 - Deborah Wilkes


Reckitt’s Nuromol has become the first combination medicine containing ibuprofen and paracetamol to be allowed on general sale outside pharmacies in the UK. The company has been awarded one year of data exclusivity for studies carried out to support the switch from pharmacy (P) to general-sale list (GSL) status.

Click tags below for more information on topics:

Reckitt MHRA

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: